Screening tests for prostate cancer include digital rectal examination (DRE), prostate-specific antigen (PSA) blood test, trans rectal ultrasound guided (TRUS) biopsy and prostate biopsy, with the latter being considered the gold standard [4]. The gene discussed is KLK3; the disease is prostate carcinoma.